Compounds > nitrates

nitrates and atorvastatin

nitrates has been researched along with atorvastatin in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's8 (57.14)29.6817
2010's4 (28.57)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Cheung, R; Mutus, B; Tannous, M; Vignini, A1
Maron, DJ1
Baldi, S; Blandizzi, C; Del Tacca, M; L'Abbate, A; Lubrano, V; Natali, A; Palombo, C; Vassalle, C1
Bendhack, LM; Castro, MM; Nagassaki, S; Rascado, RR; Rizzi, E; Tanus-Santos, JE1
Shah, DI; Singh, M3
Huang, TG; Mondo, CK; Su, JZ; Yang, WS1
Alves-Filho, JC; Cunha, FQ; Figueiredo-Lopes, L; Gerlach, RF; Semprini, MC; Souza-Costa, DC; Tanus-Santos, JE1
Sharma, PL; Sharma, S; Singh, M1
Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC1
Budhiraja, RD; Sharma, S; Tyagi, S1
Dawani, ML; Mahboob, T; Yasmeen, G1
Abdel-Razek, HAD; Abdou, AG; Hassan, MHA; Hazzaa, SM; Ibraheim, EO; Salem, EA1

Reviews

1 review(s) available for nitrates and atorvastatin

ArticleYear
Percutaneous coronary intervention versus medical therapy for coronary heart disease.
    Current atherosclerosis reports, 2000, Volume: 2, Issue:4

    Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Calcium Channel Blockers; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Male; Nitrates; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome

2000

Trials

2 trial(s) available for nitrates and atorvastatin

ArticleYear
Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:5

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Platelets; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Enzyme Induction; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Pyrroles; Treatment Outcome; Triglycerides; Tyrosine; Vasodilation

1999
Association of high-density lipoprotein cholesterol with improvement of endothelial dysfunction recovery in renovascular disease.
    Iranian journal of kidney diseases, 2015, Volume: 9, Issue:1

    Topics: Adult; Atorvastatin; Biomarkers; Cholesterol, HDL; Delayed-Action Preparations; Drug Therapy, Combination; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Kidney Diseases; Male; Middle Aged; Niacin; Nitrates; Pakistan; Pyrroles; Recovery of Function; Renal Artery; Time Factors; Treatment Outcome; Ultrasonography, Doppler

2015

Other Studies

11 other study(ies) available for nitrates and atorvastatin

ArticleYear
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides.
    European journal of clinical investigation, 2003, Volume: 33, Issue:2

    Topics: Adult; Anticholesteremic Agents; Ascorbic Acid; Atorvastatin; Cells, Cultured; Cholesterol, LDL; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Lipid Peroxidation; Lipid Peroxides; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Nitrates; Nitric Oxide Synthase; Nitrites; Pyrroles

2003
Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
    European journal of pharmacology, 2004, Sep-13, Volume: 498, Issue:1-3

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heptanoic Acids; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Acid; Nitric Oxide Synthase; Nitrites; Piperazines; Purines; Pyrroles; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents

2004
Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Molecular and cellular biochemistry, 2006, Volume: 283, Issue:1-2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antibiotics, Antineoplastic; Aorta, Thoracic; Atorvastatin; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Endothelium, Vascular; Heptanoic Acids; Homocysteine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Intracellular Signaling Peptides and Proteins; Male; Nitrates; Nitrites; Oxidative Stress; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrroles; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Streptozocin; Thiobarbituric Acid Reactive Substances; Vasodilation

2006
Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2006, Volume: 28, Issue:5

    Topics: Analysis of Variance; Animals; Atorvastatin; Biomarkers; Blood Pressure; Body Weight; Dexamethasone; Disease Models, Animal; Down-Regulation; Glucocorticoids; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Organ Size; Pyrroles; Rats; Rats, Sprague-Dawley; Superoxides; Thymus Gland

2006
Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
    Fundamental & clinical pharmacology, 2006, Volume: 20, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Atorvastatin; Blood Pressure; Cyclic AMP; Drug Administration Schedule; Endothelium, Vascular; Heptanoic Acids; Hypertension; Male; NADPH Oxidases; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Pyrroles; Rats; Rats, Sprague-Dawley; Superoxides; Thiobarbituric Acid Reactive Substances; Vasodilation

2006
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
    Critical care medicine, 2007, Volume: 35, Issue:1

    Topics: Acute Disease; Analysis of Variance; Animals; Atorvastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Injections, Intravenous; Luminescence; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microspheres; Nitrates; Nitrites; Proportional Hazards Models; Pulmonary Embolism; Pulmonary Wedge Pressure; Pyrroles; Random Allocation; Rats; Rats, Wistar; Survival Rate

2007
Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    International journal of cardiology, 2007, Sep-03, Volume: 120, Issue:3

    Topics: Animals; Aorta, Thoracic; Atorvastatin; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Male; Microscopy, Electron; Muscle Relaxation; Muscle, Smooth, Vascular; NADPH Oxidases; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Thiobarbituric Acid Reactive Substances

2007
Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B.
    Molecular and cellular biochemistry, 2011, Volume: 348, Issue:1-2

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Atorvastatin; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Male; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Vasodilation; Vasodilator Agents

2011
Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy.
    Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Nitrates; Nitrites; Pyrroles; Random Allocation; Swine; Vasodilation; Ventricular Dysfunction, Left

2011
Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:7

    Topics: Acetylcholine; Animals; Aorta, Thoracic; Atorvastatin; Blood Pressure; Desoxycorticosterone; Endothelium, Vascular; Female; Glutathione; Heptanoic Acids; Hypertension; Losartan; Male; Nitrates; Nitrites; Phosphoinositide-3 Kinase Inhibitors; Pyrroles; Rats; Rats, Wistar; Thiazolidinediones

2012
Effect of L-carnitine and atorvastatin on a rat model of ischemia-reperfusion injury of spinal cord.
    Journal of immunoassay & immunochemistry, 2021, Nov-02, Volume: 42, Issue:6

    Topics: Advanced Oxidation Protein Products; Animals; Atorvastatin; bcl-2-Associated X Protein; Carnitine; Catalase; Malondialdehyde; Nitrates; Nitrites; Rats; Reactive Oxygen Species; Reperfusion Injury; Spinal Cord; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2021